RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Prostate stem cell antigen gene is expressed in islets of pancreas

      한글로보기

      https://www.riss.kr/link?id=A99527750

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol-anchored cell surface antigen with an organ-dependent expression pattern in cancers; e.g., up-regulated in prostate cancer and down-regulated in gastric cancer. Previously it was reported that PSCA is not expressed in the normal pancreas but aberrantly expressed in pancreatic cancer. In this present study, we identified PSCA expression in islets of the pancreas by immunohistochemistry, which was co-localized with four islet-cell markers: insulin, glucagon, somatostatin and pancreatic polypeptide. In our investigation of the transcription start site of PSCA, we found a non-coding splicing variant of PSCA as well as authentic PSCA transcripts in mRNA samples from a normal pancreas. Both the transcripts were also identified in several pancreatic cancer cell lines. We previously reported that PSCA expression is correlated to the methylation status of the enhancer region in gastric and gallbladder cancer cell lines but not in pancreatic cancer cell lines, suggesting that PSCA expression is regulated in a different mode in pancreatic cancer from that in gastric and gallbladder cancers.
      번역하기

      Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol-anchored cell surface antigen with an organ-dependent expression pattern in cancers; e.g., up-regulated in prostate cancer and down-regulated in gastric cancer. Previously it was repo...

      Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol-anchored cell surface antigen with an organ-dependent expression pattern in cancers; e.g., up-regulated in prostate cancer and down-regulated in gastric cancer. Previously it was reported that PSCA is not expressed in the normal pancreas but aberrantly expressed in pancreatic cancer. In this present study, we identified PSCA expression in islets of the pancreas by immunohistochemistry, which was co-localized with four islet-cell markers: insulin, glucagon, somatostatin and pancreatic polypeptide. In our investigation of the transcription start site of PSCA, we found a non-coding splicing variant of PSCA as well as authentic PSCA transcripts in mRNA samples from a normal pancreas. Both the transcripts were also identified in several pancreatic cancer cell lines. We previously reported that PSCA expression is correlated to the methylation status of the enhancer region in gastric and gallbladder cancer cell lines but not in pancreatic cancer cell lines, suggesting that PSCA expression is regulated in a different mode in pancreatic cancer from that in gastric and gallbladder cancers.

      더보기

      목차 (Table of Contents)

      • Abstract
      • Introduction
      • Materials and Methods
      • Results
      • Discussion
      • Abstract
      • Introduction
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgements
      • References
      더보기

      참고문헌 (Reference)

      1 Grubbs EG, "Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer" 13 : 1645-1654, 2006

      2 Geiger KD, "The prostate stem cell antigen represents a novel glioma-associated antigen" 26 : 13-21, 2011

      3 Smukler SR, "The adult mouse and human pancreas contain rare multipotent stem cells that express insulin" 8 : 281-293, 2011

      4 Reiter RE, "Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer" 95 : 1735-1740, 1998

      5 Saeki N, "Prostate stem cell antigen: a Jekyll and Hyde molecule?" 16 : 3533-3538, 2010

      6 Wente MN, "Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer" 31 : 119-125, 2005

      7 Tran CP, "Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells" 1 : 113-121, 2002

      8 이연수, "Prostate Stem Cell Antigen, a Presumable Organ-Dependent Tumor Suppressor Gene, is Down-Regulated in Gallbladder Carcinogenesis" WILEY-BLACKWELL 51 (51): 30-41, 201201

      9 Desgraz R, "Pancreatic neurogenin 3-expressing cells are unipotent islet precursors" 136 : 3567-3574, 2009

      10 McCarthy DM, "Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases" 11 : 238-243, 2003

      1 Grubbs EG, "Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer" 13 : 1645-1654, 2006

      2 Geiger KD, "The prostate stem cell antigen represents a novel glioma-associated antigen" 26 : 13-21, 2011

      3 Smukler SR, "The adult mouse and human pancreas contain rare multipotent stem cells that express insulin" 8 : 281-293, 2011

      4 Reiter RE, "Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer" 95 : 1735-1740, 1998

      5 Saeki N, "Prostate stem cell antigen: a Jekyll and Hyde molecule?" 16 : 3533-3538, 2010

      6 Wente MN, "Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer" 31 : 119-125, 2005

      7 Tran CP, "Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells" 1 : 113-121, 2002

      8 이연수, "Prostate Stem Cell Antigen, a Presumable Organ-Dependent Tumor Suppressor Gene, is Down-Regulated in Gallbladder Carcinogenesis" WILEY-BLACKWELL 51 (51): 30-41, 201201

      9 Desgraz R, "Pancreatic neurogenin 3-expressing cells are unipotent islet precursors" 136 : 3567-3574, 2009

      10 McCarthy DM, "Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases" 11 : 238-243, 2003

      11 Tanaka M, "Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients" 18 : 161-166, 2007

      12 Sakamoto H, "Genetic variation in PSCA is associated with susceptibility to diff use-type gastric cancer" 40 : 730-740, 2008

      13 rom FJ, "GPI-anchored protein cleavage in the regulation of transmembrane signals" 37 : 285-315, 2004

      14 Argani P, "Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma" 61 : 4320-4324, 2001

      15 Kawaguchi T, "Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer" 40 : 319-326, 2010

      16 Morris MJ, "A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer" 2012

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 계속평가 신청대상 (계속평가)
      2020-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2019-12-01 평가 등재후보 탈락 (계속평가)
      2018-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-02-02 학술지명변경 한글명 : 대한해부학회지 -> Anatomy and Cell Biology
      외국어명 : The Korean Journal of Anatomy -> Anatomy and Cell Biology
      KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2006-01-01 평가 등재후보로 하락 (등재유지) KCI등재후보
      2004-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.15 0.15 0.1
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.1 0.09 0.223 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼